Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. Co. operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. Its other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise.
When researching a stock like Incyte, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from INCY Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for INCY stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the INCY 200 day moving average ("INCY 200 DMA"), while one of the most popular "shorter look-backs" is the INCY 50 day moving average ("INCY 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Incyte. Comparing two moving averages against each other can be a useful visualization tool: by calculating the difference between the INCY 200 DMA and the INCY 50 DMA, we get a moving average convergence divergence indicator ("INCY MACD"). The INCY MACD chart, in conjunction with the chart of the moving averages, basically helps in visualizing how the moving averages are showing convergence (moving closer together), or divergence (moving farther apart). |
Free INCY Email Alerts:
Video: Technical Analysis